Understanding Barriers to Hepatitis C Antiviral Treatment in Low–Middle-Income Countries
Open Access
- 30 December 2024
- journal article
- review article
- Published by MDPI AG in Healthcare
- Vol. 13 (1) , 43
Abstract
Background: Direct-acting antiviral agents (DAAs) have significantly reduced Hepatitis C Virus (HCV) transmission and improved health outcomes since their FDA approval in 2011. Despite these advances, over 70 million people remain untreated globally, with a disproportionately high burden in low- and middle-income countries (LMICs). Methods: Through a structured search of open access informational sources and an informal peer-reviewed literature review, HCV treatment barriers were identified, compiled, and analyzed. Current challenges to HCV treatment were organized by themes and summarized as recommendations for LMICs. Results: Key obstacles to HCV treatment in LMICs are identified, with the underdiagnosis and undertreatment of the disease linked to inadequate funding and healthcare infrastructure for screening and testing, poor awareness among healthcare providers, and the misinformation and stigmatization of HCV disease. Discussion: Recommendations for LMICs to attenuate treatment obstacles include distributing educational media, implementing mobile clinics, and fostering international partnerships. The successful implementation of these interventions has been demonstrated in developed countries. Conclusions: To achieve the WHO’s goal of eliminating HCV as a public health threat by 2030, concerted efforts are needed by LMICs to reduce gaps in care and ensure that all patients are afforded access to testing and treatment.Keywords
This publication has 30 references indexed in Scilit:
- Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictionsThe Lancet Gastroenterology & Hepatology, 2024
- Implementation of a mobile health clinic framework for Hepatitis C virus screening and treatment: a descriptive studyThe Lancet Regional Health - Americas, 2023
- Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination EffortsJournal of General Internal Medicine, 2022
- Formal Hepatitis C Education Increases Willingness to Receive Therapy in an On-site Shelter-Based HCV Model of Care in Persons Experiencing HomelessnessOpen Forum Infectious Diseases, 2022
- Hepatitis C-related knowledge, attitudes and perceived risk behaviours among people who inject drugs in Kenya: A qualitative studyGlobal Public Health, 2021
- The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goalsJournal of Virus Eradication, 2019
- Ten priorities for expanding access to HCV treatment for people who inject drugs in low- and middle-income countriesInternational Journal of Drug Policy, 2015
- A path to eradication of hepatitis C in low- and middle-income countriesAntiviral Research, 2015
- Effect of Providing Conditional Economic Compensation on Uptake of Voluntary Medical Male Circumcision in KenyaJAMA, 2014
- A global view of hepatitis C: Physician knowledge, opinions, and perceived barriers to careHepatology, 2013